Skip to main content
Graphic of all Rare Disease Network Consortia

Who We Are

The RDCRN program is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study nearly 200 rare diseases at sites across the nation.

Learn About Our Consortia Learn About Our Data Management Coordinating Center
Purple icon depicting a piece of paper with writing on it
20

Research groups funded

Purple magnifying glass icon
200+

Diseases studied

A purple icon depicts three people
170

Patient advocacy partners

Artificial Intelligence-Powered Telemedicine Tool Automates Scoring of Neuromuscular Examinations in Myasthenia Gravis

Researchers from MGNet harnessed artificial intelligence to develop a new, automated tool for neuromuscular assessments in myasthenia gravis.

Image
Screenshot of the graphic user interface used by doctors for remote examinations. Source: Bioengineering journal

Rare Research Report: October 2024

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications.

Image
Rare Research Report logo

Pompe Disease Over Time: What We’re Learning from a Natural History Study

To learn more about Pompe disease, the Lysosomal Disease Network (LDN) is conducting a natural history study, “Lysosomal Disease Network Longitudinal Study of Pompe Disease.”

Image
Pompe Disease Over Time: What We're Learning from a Natural History Study


Rare Research Report Podcast

Listen to "Rare Research Report" on Spreaker.


 

Training The Next Generation

Training the Next Generation of Researchers

Our consortia place a high priority on the recruitment, training and support of early career researchers due to the significant need for well-trained clinical researchers in the rare diseases field.

Find Opportunities

Information for Patients and Families

Our network focuses on clinical research and does not generally support clinical care outside research activities. View the diseases that we currently study here. To learn about other rare diseases, visit the NIH’s Genetic and Rare Diseases Information Center (GARD), which helps the public reliable information about rare and genetic diseases. Contact their specialists at 888-205-2311 or email GARDinfo@nih.gov.

NIH Funding Institutes, Centers, and Offices

Established by Congress under the Rare Diseases Act in 2002, RDCRN is an initiative of the Division of Rare Diseases Research Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences. Our network, now in its fourth five-year funding cycle, is a partnership with funding and programmatic support provided by Institutes, Centers and Offices across NIH.